Useful resources

Standard Operating Procedures (SOPs) & Standards

METRINO practical resources

Measurement SOPs, protocols and good-practice guidance

This page brings together METRINO project results, practical guidance for finding the right method, and selected external standards and protocol resources.

Check the scope before use or reuse. Each procedure was developed or evaluated with specific materials, matrices and model systems. Always verify its scope, conditions and limitations in the linked deliverable before applying it to a new system.

New to SOPs? Give me the 30-second version

01 · METRINO project results

Find a method through three pathways

Choose the pathway that best matches your sample and measurement question. The linked deliverables remain the authoritative source for every method’s scope, conditions and limitations.

Pathway 1

Characterise a nanomaterial

Filter the catalogue by measurement need. Each card identifies the technique, the materials used to develop or test the procedure, and its section in the D3 good practice guide. D3 also contains broader decision tables: a method or material listed in those tables does not necessarily have a dedicated SOP.

Filter by measurement need

Showing 9 procedures

Size and concentration

SAXS

Determine particle size using laboratory or synchrotron SAXS

Measures
Mean diameter and size distribution
Applied to
Polydisperse iron oxide nanoparticles

Deliverable D3 · Section 4.1

SAXS

Determine particle number concentration using synchrotron SAXS

Measures
Particle number concentration
Applied to
Small iron oxide nanoparticles

Deliverable D3 · Section 4.2

AFM + SEM

Evaluate particle dimensions using hybrid microscopy

Measures
Lateral dimensions and particle height
Applied to
Hafnium dioxide nanoparticles

Deliverable D3 · Section 4.3

MD-AF4

Evaluate nanoparticle size after fractionation

Measures
Size distribution in liquid using complementary detectors
Applied to
Iron oxide nanoparticles

Deliverable D3 · Section 4.4

DLS

Determine hydrodynamic particle size

Measures
Hydrodynamic size and size distribution
Applied to
Monodisperse citrate-coated iron oxide nanoparticles

Deliverable D3 · Section 4.5

Surface properties

TGA

Quantify surface coating amount and homogeneity

Measures
Organic surface coating amount and homogeneity
Applied to
HfO₂, FeraSpin and iron oxide nanoparticles

Deliverable D3 · Section 5.1

ATR-FTIR

Assess surface chemical composition and homogeneity

Measures
Chemical composition of nanoparticle surface coatings
Applied to
HfO₂ and FeraSpin samples

Deliverable D3 · Section 5.2

XPS

Determine elemental surface composition

Measures
Elemental composition of nanoparticle surfaces
Applied to
FeraSpin R-like nanoparticle dispersions

Deliverable D3 · Section 5.3

qNMR

Quantify nanoparticle surface ligands

Measures
Identity and quantity of surface ligands in solution
Applied to
Citrate-stabilised iron oxide nanoparticles

Deliverable D3 · Section 5.4

D3: Good practice guide and repository of tested SOPsAccess the nine procedures and the broader decision tables for size, concentration and surface characterisation. Version 1 · published 13 July 2026 · DOI 10.5281/zenodo.21641655 · CC BY 4.0.
Access Deliverable D3
Working with lipid nanoparticles or liposomes?D3 focuses on the procedures catalogued above. The WP2 results page also explains METRINO work on advanced chemical and structural characterisation of lipid-based nanoparticles, including complementary scattering, microscopy and analytical approaches.
Explore WP2 context

Pathway 2

Prepare, separate and characterise nanoparticles in liquid biological matrices

Start with the sample and liquid matrix, then choose an analytical workflow that fits the nanoparticle system and measurement question. For cells, tissues or tissue phantoms, continue to Pathway 3.

Step 1

Prepare and control the sample

D5 provides procedures for spiking, extraction and fractionation in matrices of increasing complexity.

Review sample preparation
Step 2

Select an analytical workflow

D6 describes five fractionation, characterisation and direct-analysis workflows for specific nanoparticle classes.

Find an analytical workflow

Step 1: Prepare the sample and manage matrix effects

Spiking in PBS and simulated blood mediumSection 4.1
Spiking in 10% fetal bovine serumSection 4.2
Chemical and enzymatic extractionSections 5–6
AF4 fractionation approachesSection 7
D5: Sample preparation and measurement protocolsUse the public report to check sample-specific conditions, limitations and example datasets. Version 2 · published 24 July 2026 · DOI 10.5281/zenodo.21536481 · CC BY 4.0.
Open D5

Step 2: Select an analytical workflow

D6 reports validation and performance evidence for selected fractionation methods. It also includes a complementary SAXS good-practice workflow, which is not presented as a rigid SOP.

Filter by nanoparticle system

Showing 5 workflows

MD-AF4

Fractionate and characterise lipid nanoparticles

System
mRNA-loaded LNPs
Includes
Instrument setup, step-by-step procedure and application to biological matrices

Deliverable D6 · Section 5.1

MD-AF4

Fractionate and characterise liposomes

System
Small PEGylated and large non-PEGylated liposomes
Includes
Quality control, data analysis, limitations and matrix application

Deliverable D6 · Section 5.2

MD-AF4

Fractionate and characterise metal oxide nanoparticles

System
Iron oxide and hafnium oxide nanoparticles
Includes
Instrument setup, data analysis, critical parameters and limitations

Deliverable D6 · Section 5.3

SEC-MALS

Characterise lipid nanoparticles using SEC-MALS

System
Lipid nanoparticles
Use when
A faster, simpler separation is appropriate for the sample size and distribution

Deliverable D6 · Section 5.4

SAXS

Analyse nanoparticles directly in biological media

System
Nanoparticles with sufficient scattering contrast
Use when
Structural information is needed without prior fractionation

Deliverable D6 · Section 5.5

D6: Fractionation and characterisation protocolsAccess the full workflows, performance evidence, limitations and reporting guidance in the public report.
Open D6

Pathway 3

Detect, localise or quantify nanoparticles in cells and tissues

Use D7 to identify protocols for preparing biological and synthetic model systems and for measuring nanoparticle uptake or distribution. Use D8 to understand how selected orthogonal techniques performed in the internal interlaboratory comparison.

Filter by measurement need

Showing 10 resources

Prepare biological and synthetic model systems

Epoxy phantom

Prepare homogeneous tissue-mimicking phantoms

Purpose
Instrument calibration and controlled nanoparticle concentration
Model
Nanoparticle-spiked epoxy phantoms

Deliverable D7 · Preparation protocol

3D tissue model

Build engineered SISmuc cancer models

Purpose
Three-dimensional in vitro evaluation
Model
SISmuc scaffolds used as engineered tumour models

Deliverable D7 · Preparation protocol

Cartilage model

Prepare chondrocyte pellet and punch models

Purpose
Controlled human cell and tissue-like model preparation
Model
Human articular chondrocyte pellets and punches

Deliverable D7 · Preparation protocol

Histology

Spike, embed and section animal tissues

Purpose
Prepare tissues for spatial and quantitative analysis
Includes
Liver, spleen and lung spiking; paraffin embedding, cryosectioning and deparaffinisation

Deliverable D7 · Tissue preparation workflow

Image, localise and quantify

LA-ICP-TOF-MS

Map elemental distributions in two dimensions

Measures
Spatially resolved elemental signals and nanoparticle distribution
Applied to
Sections of tissue and model samples

Deliverable D7 · Analytical SOP

scICP-MS

Quantify nanoparticle-associated mass in individual cells

Measures
Cell-resolved elemental mass
Critical point
Transport efficiency and cell integrity require careful control

Deliverable D7 · Analytical SOP

Digestion + ICP-OES

Quantify Group IV metal oxides after digestion

Measures
Total elemental content
Includes
Microwave digestion using sulfuric acid/peroxide mixtures

Deliverable D7 · Analytical SOP

TPEF

Image nanoparticle distribution in depth

Measures
Three-dimensional fluorescence distribution
Use when
Deep-tissue optical imaging is required

Deliverable D7 · Imaging SOP

ToF-SIMS

Map surface chemistry and nanoparticle localisation

Measures
Spatially resolved chemical signatures
Use when
High-resolution surface chemical mapping is required

Deliverable D7 · Imaging SOP

Inverted light microscopy

Assess model morphology alongside nanoparticle measurements

Measures
Morphological features of cells and engineered models
Role
Complementary structural context for analytical measurements

Deliverable D7 · Imaging protocol

D7: Tissue, tissue-phantom and cellular measurement protocolsAccess the preparation and analytical SOPs for uptake, distribution, imaging and quantification. Version 1 · published 30 April 2026 · DOI 10.5281/zenodo.21537147 · CC BY 4.0.
Access Deliverable D7

D8: Interlaboratory evidence supporting the pathway

The internal ILC compared complementary approaches across increasing biological complexity. It supports method selection and exposes practical limits; it does not make every method interchangeable or universally validated. Version 1 · published 30 April 2026 · DOI 10.5281/zenodo.21641447 · CC BY 4.0.

Read the D8 ILC report
Epoxy phantoms SISmuc 3D tumour models HfO₂-spiked mouse liver A549 cells

Key interpretation: D8 correlated TPEF, LA-ICP-MS and ToF-SIMS data through a custom image-registration pipeline and found good agreement between LA-ICP-MS and bulk ICP-MS for HfO₂ uptake. Single-cell ICP-MS remained challenging because of low transport efficiency and cell disruption during injection. These limitations should guide reuse.

Before using a METRINO procedure

Four checks for reliable reuse

A procedure is one part of a reliable measurement workflow. Before applying it to a new system, confirm that the measurement question, sample, controls and reporting requirements are appropriate.

Define the measurement questionSpecify the material, matrix, measurand and intended use.
Check the stated scopeCompare your sample with the materials and conditions evaluated.
Follow the controlsApply the stated preparation, calibration and quality requirements.
Report conditions and limitationsDocument settings, treatment steps, limitations and performance.
See the performance dimensions assessed in D6

The dimensions reported depend on the workflow and evidence available.

RecoveryHow much analyte is recovered through the workflow
PrecisionRepeatability and, where assessed, reproducibility
Accuracy and resolutionAgreement with reference values and separation performance
Carryover and uncertaintyResidual sample effects and confidence in reported values

Beyond METRINO

Continue your search

Explore trusted standards bodies, pharmacopoeial resources and complementary protocol libraries relevant to nanomedicine measurement.

Researchers carrying out particle analysis in liquid in a laboratory
Particle analysis in liquid · METRINO laboratory activity
The 30-second version

SOPs and standards — the simple version

Think of an SOP as a carefully written recipe for a defined measurement. Protocols and good-practice guides can add context and choices. A formal standard goes further: it is developed through an organised consensus process.

SOPStep-by-step instructions for carrying out a defined process or measurement within a stated scope.
Protocol or good-practice guidePractical guidance combining procedures, choices, controls, data treatment or limitations.
StandardA consensus-built technical document adopted through a formal standards or compendial process.

The key point: METRINO produced procedures and technical evidence. These may support future standardisation, but they are not themselves formal standards.

From a project result to wider consensus

How a procedure may contribute to future standardisation

A documented procedure can support comparative evidence and technical discussion. Formal standardisation still requires an independent consensus and adoption process.

1Documented procedureScope, controls and reporting requirements
2Comparative evidencePerformance studies or interlaboratory work
3Possible consensus pathwayFurther evaluation by the relevant community or body

This pathway is not automatic and does not imply that a METRINO procedure has already been adopted as a formal standard.

Existing standards and consensus pathways

Use these entry points to explore technical committees, test guidance, interlaboratory pathways and pharmacopoeial information.

International standardisation

ISO/TC 229 — Nanotechnologies

Work programme covering terminology, metrology, reference materials, test methods, modelling, and health and safety aspects of nanotechnologies.

European standardisation

CEN/TC 352 — Nanotechnologies

European standards activity on classification, terminology, metrology, instrumentation, test methods, modelling and simulation for nanotechnologies.

Test methods and terminology

ASTM Committee E56 — Nanotechnology

ASTM committee activity related to standards and guidance for nanotechnology, including characterisation and related terminology.

Interlaboratory evidence

VAMAS TWA 40 — Synthetic Biomaterials

International pre-standardisation activity using collaborative studies and intercomparisons for materials and technologies relevant to biological applications.

Test guidance

OECD Test Guidelines — Physical-chemical properties

Internationally recognised test guidance for physical-chemical properties, including methods that may be relevant when assessing nanomaterials.

European pharmacopoeial resources

European Pharmacopoeia and EDQM Knowledge Database

Official information on European Pharmacopoeia texts, monographs and reference information for medicines and their ingredients.

US compendial standards

USP–NF

Compendial standards and supporting information for medicines, dosage forms, drug substances, excipients and related analytical approaches.

Protocol and good-practice libraries

Complement the METRINO deliverables with established assay collections, methods manuals and measurement guidance from trusted organisations.

Nanomedicine characterisation

NCI Nanotechnology Characterization Laboratory

Protocols and capabilities spanning physicochemical characterisation, in vitro analysis and preclinical evaluation of nanotechnology-based products.

Translational assessment

EUNCL Assay Cascade

A structured set of physicochemical, in vitro and in vivo assays developed to support characterisation of nanomedicine candidates.

Particle measurement methods

NanoDefine Methods Manual — Part 3

A European methods manual gathering SOPs used within the NanoDefine framework for particle measurement and material classification.

Measurement good practice

NPL Good Practice Guides

A broad collection of practical measurement guidance published by the UK National Physical Laboratory across multiple technical domains.

Nanomaterial procedures

nanopartikel.info Operating Instructions

Practical operating instructions and laboratory guidance for selected nanomaterial preparation and measurement activities.

External resources are maintained by their respective organisations. Their inclusion provides routes for further exploration and does not imply that every resource was developed, validated or formally endorsed by METRINO.

Metrology for Innovative Nanotherapeutics
Get Social

The METRINO project has received funding from the European Partnership on Metrology (Grant #22HLT04), co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.

© 2026 — The METRINO Project